Log in to save to my catalogue

ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice

ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1915343409

ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice

About this item

Full title

ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice

Publisher

United States: American Association for the Advancement of Science

Journal title

Science (American Association for the Advancement of Science), 2017-08, Vol.357 (6352), p.707-713

Language

English

Formats

Publication information

Publisher

United States: American Association for the Advancement of Science

More information

Scope and Contents

Contents

Preeclampsia (PE) is a gestational hypertensive syndrome affecting between 5 and 8% of all pregnancies. Although PE is the leading cause of fetal and maternal morbidity and mortality, its molecular etiology is still unclear. Here, we show that ELABELA (ELA), an endogenous ligand of the apelin receptor (APLNR, or APJ), is a circulating hormone secre...

Alternative Titles

Full title

ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1915343409

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1915343409

Other Identifiers

ISSN

0036-8075

E-ISSN

1095-9203

DOI

10.1126/science.aam6607

How to access this item